Ledger.Open graph →
SEC Form D · filed September 5, 2018

Ascus Biosciences, Inc

Offering
$8.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

John Watson · Evergreen, CODirectorBrian Lee · Los Angeles, CADirectorKevin Meredith · TAMPA, FLDirectorAndre Hampton · TAMPA, FLExec · DirectorEmil Bodenstein · LUTZ, FLDirectorMatthew Luckett · Brooklyn, NYExec · DirectorAndrew Benson · Lincoln, NEDirectorTimothy Brummels · Lincoln, NEDirectorXiangyan Sun · Brooklyn, NYExec · DirectorYimin Qian · Brooklyn, NYDirectorQuan Zhou · Brooklyn, NYDirectorKe Liu · Brooklyn, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗